On September 8, 2022, the 22nd China International Investment and Trade Fair (referred to as "Investment Fair") opened in Xiamen. The company was invited to participate in the exhibition of the results of Fuzhou Pavilion.
At the investment fair, our company promoted drugs such as "moxaprime citrate tablets", "sinacase hydrochloride tablets" and "valsartan amlodipine tablets" through on-site physical display and special introduction, so that investors and the public can have a deeper understanding of the products developed by the company and the company.
Through this exhibition, the company's pharmaceutical brand communication and product promotion have been strengthened, and market awareness and brand awareness have been further enhanced.
